We discuss how adjuvants engaging this pathway might enhance protective TH2 immunity to parasitic infections while drugs that block the activity of Chi3l1 in DCs and CD4 T cells might prevent damaging TH2 responses in the settings of allergic inflammation. This evidence concerns the gene CHI3L1 and parasitic infectious disease.